These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36604959)

  • 1. Metabolite Changes during the Transition from Hyperthyroidism to Euthyroidism in Patients with Graves' Disease.
    Lee HY; Sim BC; Nga HT; Moon JS; Tian J; Linh NT; Ju SH; Choi DW; Setoyama D; Yi HS
    Endocrinol Metab (Seoul); 2022 Dec; 37(6):891-900. PubMed ID: 36604959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' Disease.
    Chng CL; Lim AY; Tan HC; Kovalik JP; Tham KW; Bee YM; Lim W; Acharyya S; Lai OF; Chong MF; Yen PM
    Thyroid; 2016 Oct; 26(10):1422-1430. PubMed ID: 27465032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.
    Mazza E; Carlini M; Flecchia D; Blatto A; Zuccarini O; Gamba S; Beninati S; Messina M
    J Endocrinol Invest; 2008 Oct; 31(10):866-72. PubMed ID: 19092290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
    Bayramoğlu E; Elmaogulları S; Sagsak E; Aycan Z
    J Pediatr Endocrinol Metab; 2019 Apr; 32(4):341-346. PubMed ID: 30862763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Application of Quantitative Single-Photon Emission Computed Tomography/Computed Tomography to Predict Early Response to Methimazole in Graves' Disease.
    Kim HJ; Bang JI; Kim JY; Moon JH; So Y; Lee WW
    Korean J Radiol; 2017; 18(3):543-550. PubMed ID: 28458607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels.
    Al-Majdoub M; Lantz M; Spégel P
    Thyroid; 2017 Sep; 27(9):1109-1117. PubMed ID: 28699427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to Normalization and Sustainable Normal Serum Thyrotropin Concentrations in Patients with Hyperthyroidism: Comparison of Methimazole and Radioactive Iodine Treatments.
    Azizi F; Saadat N; Abdi H; Mehran L; Masoumi S; Takyar MA; Amouzegar A
    Endocr Pract; 2022 Nov; 28(11):1140-1145. PubMed ID: 35948251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy.
    Kruljac I; Solter D; Vrkljan AM; Solter M
    Endocr Res; 2015; 40(1):25-8. PubMed ID: 24833206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of body weight in patients with Graves' disease during the treatment with methimazole].
    Moretto RL; Pedro AB; Leite AC; Romaldini JH
    Arq Bras Endocrinol Metabol; 2012 Aug; 56(6):364-9. PubMed ID: 22990640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Differential Effects of Propylthiouracil and Methimazole as Graves' Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial.
    Wisnu W; Alwi I; Nafrialdi N; Harimurti K; Pemayun TGD; Jusman SWA; Santoso DIS; Harahap AR; Suwarto S; Subekti I
    Front Endocrinol (Lausanne); 2021; 12():796194. PubMed ID: 34987480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
    Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
    Kallner G; Vitols S; Ljunggren JG
    J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy.
    Yoshihara A; Noh JY; Watanabe N; Kunii Y; Suzuki M; Matsumoto M; Suzuki N; Hiruma M; Morisaki M; Kawaguchi A; Sugino K; Ito K
    Thyroid; 2020 Mar; 30(3):451-456. PubMed ID: 31928169
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic effects of brown fat in transitioning from hyperthyroidism to euthyroidism.
    Sun L; Goh HJ; Verma S; Govindharajulu P; Sadananthan SA; Michael N; Jadegoud Y; Henry CJ; Velan SS; Yeo PS; Lee Y; Lim BSP; Liew H; Chew CK; Quek TPL; Abdul Shakoor SAKK; Hoi WH; Chan SP; Chew DE; Dalan R; Leow MKS
    Eur J Endocrinol; 2021 Aug; 185(4):553-563. PubMed ID: 34342595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves' disease.
    Setoyama D; Lee HY; Moon JS; Tian J; Kang YE; Lee JH; Shong M; Kang D; Yi HS
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):355-367. PubMed ID: 34970859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metamorphic thyroid autoimmunity in Down Syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond.
    Aversa T; Valenzise M; Salerno M; Corrias A; Iughetti L; Radetti G; De Luca F; Wasniewska M
    Ital J Pediatr; 2015 Nov; 41():87. PubMed ID: 26558364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy.
    Antonelli A; Ferrari SM; Corrado A; Ferrannini E; Fallahi P
    Thyroid; 2013 Nov; 23(11):1461-9. PubMed ID: 23721189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Metabolomics Study in Children With Graves' Disease.
    Xia Q; Qian W; Chen L; Chen X; Xie R; Zhang D; Wu H; Sun H; Wang F; Liu J; Chen T
    Front Endocrinol (Lausanne); 2021; 12():752496. PubMed ID: 34867796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.